AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7931525 — intervention group
Group type: EXPERIMENTAL
Intervention: Total number of pulses in a sweep (eight or more).
Number of subjects: 0
Study 3323074 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime single preoperative 2 g intramuscular dose (group A)
Number of subjects: 200
Study 3323074 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 3 perioperative 1 g intramuscular doses every 6 h (group B)
Number of subjects: 200
Study 31361656 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho-k group 1 (target myopia reduction of 6.00 D)
Number of subjects: 102
Study 31361656 — intervention group
Group type: EXPERIMENTAL
Intervention: Ortho-k group 2 (target myopia reduction of 4.00 D)
Number of subjects: 102
Study 31361656 — intervention group
Group type: COMPARATOR
Intervention: Control group (single-vision spectacles)
Number of subjects: 102
Study 31290466 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.3% dextrose in 0.18% saline (Group I)
Number of subjects: 65
Study 31290466 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal saline (Group II)
Number of subjects: 65
Study 31290466 — intervention group
Group type: EXPERIMENTAL
Intervention: Ringer's lactate (Group III)
Number of subjects: 65
Study 27336592 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Kids-Houston program (3 sessions of 6 weeks, 2 sessions per week, 2 hours each session with 90 minutes of physical activity and 30 minutes of nutrition lessons)
Number of subjects: 877
Study 27336592 — intervention group
Group type: COMPARATOR
Intervention: Control group (typical enrichment programs)
Number of subjects: 877
Study 24834773 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with Pru p 3-enriched peach extract
Number of subjects: 0
Study 22459675 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa therapy
Number of subjects: 0
Study 22459675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 20489032 — intervention group
Group type: EXPERIMENTAL
Intervention: High-CHO (H-CHO; 71 ± 3% CHO)
Number of subjects: 6
Study 20489032 — intervention group
Group type: COMPARATOR
Intervention: Low-CHO (L-CHO; 11 ± 1% CHO)
Number of subjects: 6
Study 18457717 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0
Study 18457717 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous treatment with distal protection
Number of subjects: 0
Study 15670265 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and pelvic exercise
Number of subjects: 23
Study 15670265 — intervention group
Group type: COMPARATOR
Intervention: Education and biofeedback (BF) therapy
Number of subjects: 23
Study 12200980 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg/kg/24 h ferrous sulphate given orally for 3 months
Number of subjects: 18
Study 12200980 — intervention group
Group type: COMPARATOR
Intervention: Control group (12 healthy children; 6 boys, 6 girls; mean age 29 +/- 1.3 months)
Number of subjects: 18
Study 10355008 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver fluoride/stannous fluoride (AgF/SnF2)
Number of subjects: 85
Study 10355008 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver nitrate (AgNO3)
Number of subjects: 85
Study 10355008 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diammine fluoride (SDF)
Number of subjects: 85
Study 10355008 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX)
Number of subjects: 85
Study 10355008 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study 8942398 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb immobilization for 1 week
Number of subjects: 11
Study 8942398 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb immobilization for 6 weeks
Number of subjects: 11
Study 8942398 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb immobilization for 6 weeks (free leg)
Number of subjects: 11
Study 8942398 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb immobilization for 1 week (free leg)
Number of subjects: 11
Study 8942398 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb immobilization for 1 or 6 weeks
Number of subjects: 11
Study 1775602 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline (NTL)
Number of subjects: 0
Study 1775602 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 0
Study 7147151 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (1g daily for one week)
Number of subjects: 71
Study 7147151 — intervention group
Group type: COMPARATOR
Intervention: Tetracycline (1g daily for one week)
Number of subjects: 71
Study 30378203 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with two meals of 150 g of cooked fatty fish weekly
Number of subjects: 64
Study 30378203 — intervention group
Group type: COMPARATOR
Intervention: Usual diet
Number of subjects: 64
Study 27999848 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-nourished patients
Number of subjects: 292
Study 27999848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional status improvement
Number of subjects: 292
Study 27999848 — intervention group
Group type: EXPERIMENTAL
Intervention: Trajectories of nutritional status
Number of subjects: 292
Study 27999848 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive function trajectories
Number of subjects: 292
Study 25442659 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigation fluid with epinephrine
Number of subjects: 83
Study 25442659 — intervention group
Group type: COMPARATOR
Intervention: Irrigation fluid without epinephrine
Number of subjects: 83
Study 24992751 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture + massage + blocking therapy
Number of subjects: 86
Study 24992751 — intervention group
Group type: COMPARATOR
Intervention: Blocking therapy alone
Number of subjects: 86
Study 22587485 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 50
Study 22587485 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser therapy
Number of subjects: 50
Study 22587485 — intervention group
Group type: EXPERIMENTAL
Intervention: LED therapy
Number of subjects: 50
Study 22587485 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and laser therapy
Number of subjects: 50
Study 22587485 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation and LED therapy
Number of subjects: 50
Study 17724210 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical clonidine
Number of subjects: 12
Study 17724210 — intervention group
Group type: COMPARATOR
Intervention: Topical brimonidine
Number of subjects: 12
Study 15038091 — intervention group
Group type: EXPERIMENTAL
Intervention: LPZ(60 mg/d) alone
Number of subjects: 3
Study 15038091 — intervention group
Group type: EXPERIMENTAL
Intervention: LPZ(60 mg/d) with CAM(400 mg/d) and AMPC(1,500 mg/d)
Number of subjects: 3
Study 15038091 — intervention group
Group type: EXPERIMENTAL
Intervention: LPZ(60 mg/d) with CAM(800 mg/d) and AMPC(1,500 mg/d)
Number of subjects: 3
Study 11346854 — intervention group
Group type: EXPERIMENTAL
Intervention: PAPAW
Number of subjects: 11
Study 9547961 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-sensory environment (MSE)
Number of subjects: 27
Study 9547961 — intervention group
Group type: COMPARATOR
Intervention: Control condition (non-complex sensory environment)
Number of subjects: 27
Study 7982254 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam (1 to 2 g ampicillin and 0.5 to 1 g sulbactam, administered intravenously once every 6 hours)
Number of subjects: 85
Study 7982254 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime (750 mg to 1.5 g, administered intravenously once every 8 hours)
Number of subjects: 85
Study 7982254 — intervention group
Group type: EXPERIMENTAL
Intervention: Ampicillin/sulbactam
Number of subjects: 85
Study 7982254 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 85
Study 7982254 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 85
Study 2600246 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week group treatment program
Number of subjects: 76
Study 2600246 — intervention group
Group type: EXPERIMENTAL
Intervention: Graduated exposure procedures
Number of subjects: 76
Study 2600246 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective evaluation method and social comparison method
Number of subjects: 76
Study 31518550 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal placental growth factor (>100 pg/mL)
Number of subjects: 753
Study 31518550 — intervention group
Group type: COMPARATOR
Intervention: Placental growth factor ≤100 pg/mL
Number of subjects: 753
Study 31518550 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental growth factor <12 pg/mL
Number of subjects: 753
Study 31518550 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental growth factor 12-100 pg/mL
Number of subjects: 753
Study 29642710 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based communication training
Number of subjects: 45
Study 29642710 — intervention group
Group type: COMPARATOR
Intervention: Didactic session
Number of subjects: 45
Study 27350268 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous wound infiltration (CWI) with 0.2% ropivacaine
Number of subjects: 48
Study 27350268 — intervention group
Group type: COMPARATOR
Intervention: Single intercostal nerve block (ICNB) with 10 ml of 0.75% ropivacaine
Number of subjects: 48
Study 24960095 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep oscillation treatment applied for at least one week following the operation.
Number of subjects: 40
Study 24960095 — intervention group
Group type: COMPARATOR
Intervention: Control group (no deep oscillation treatment).
Number of subjects: 40
Study 22061048 — intervention group
Group type: EXPERIMENTAL
Intervention: Perturbation training
Number of subjects: 21
Study 19819439 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic scalpel
Number of subjects: 160
Study 19819439 — intervention group
Group type: COMPARATOR
Intervention: Electrosurgery
Number of subjects: 160
Study 18812670 — intervention group
Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 91
Study 18812670 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone plus Irbesartan
Number of subjects: 91
Study 14987329 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 60 mg orlistat
Number of subjects: 40
Study 14987329 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 x 120 mg orlistat
Number of subjects: 40
Study 14987329 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11433843 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopic nasosinus surgery (FENS)
Number of subjects: 64
Study 11433843 — intervention group
Group type: COMPARATOR
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 64
Study 9720728 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy with autologous stem cell transplantation (ASCT)
Number of subjects: 171
Study 7731900 — intervention group
Group type: EXPERIMENTAL
Intervention: T and B lymphocytes
Number of subjects: 17
Study 7731900 — intervention group
Group type: EXPERIMENTAL
Intervention: B lymphocytes
Number of subjects: 17
Study 7731900 — intervention group
Group type: EXPERIMENTAL
Intervention: T cells
Number of subjects: 17
Study 2736420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg etomidate (group I; n = 6)
Number of subjects: 18
Study 2736420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg etomidate (group II; n = 6)
Number of subjects: 18
Study 2736420 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg etomidate (group III; n = 6)
Number of subjects: 18
Study 30907769 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving training program (eight sessions over 4 weeks)
Number of subjects: 72
Study 30907769 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 72
Study 31162756 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference-delivered mobile health pain coping skills training (mPCST)
Number of subjects: 178
Study 31162756 — intervention group
Group type: COMPARATOR
Intervention: In-person pain coping skills training (PCST-traditional)
Number of subjects: 178
Study 28397524 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrox28
Number of subjects: 108
Study 28397524 — intervention group
Group type: COMPARATOR
Intervention: Air
Number of subjects: 108
Study 28397524 — intervention group
Group type: EXPERIMENTAL
Intervention: Female divers
Number of subjects: 108
Study 24901734 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg/day
Number of subjects: 0
Study 24901734 — intervention group
Group type: COMPARATOR
Intervention: Bendamustine and Rituximab (BR)
Number of subjects: 0
Study 23410553 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait parameters (forward displacement category: speed, stride length, hip flexion, knee flexion)
Number of subjects: 90
Study 23410553 — intervention group
Group type: EXPERIMENTAL
Intervention: Gait parameters (frontal category: thorax obliquity, knee adductor moments)
Number of subjects: 90
Study 23410553 — intervention group
Group type: EXPERIMENTAL
Intervention: WOMAC Index for pain and function assessment
Number of subjects: 90
Study 23410553 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip-knee-ankle angle on full-limb radiography for knee joint deformity assessment
Number of subjects: 90
Study 23410553 — intervention group
Group type: EXPERIMENTAL
Intervention: Full body gait analysis using motion analysis system and force plates
Number of subjects: 90
Study 22177541 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative fluid loading with 25 ml/kg of Ringer's solution in the six hours before surgery
Number of subjects: 111
Study 22177541 — intervention group
Group type: COMPARATOR
Intervention: Control group with no pre-operative fluid loading
Number of subjects: 111
Study 22177541 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative fluid loading
Number of subjects: 111
Study 19818722 — intervention group
Group type: EXPERIMENTAL
Intervention: 11-valent pneumococcal protein D conjugate vaccine
Number of subjects: 0
Study 16513447 — intervention group
Group type: EXPERIMENTAL
Intervention: Telithromycin 800 mg
Number of subjects: 12
Study 16513447 — intervention group
Group type: COMPARATOR
Intervention: Montelukast 10 mg
Number of subjects: 12
Study 16513447 — intervention group
Group type: COMPARATOR
Intervention: Combination of telithromycin and montelukast
Number of subjects: 12
Study 16513447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 15568664 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex drug and laser therapy
Number of subjects: 100
Study 15568664 — intervention group
Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 100
Study 10657288 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (200 mg)
Number of subjects: 26
Study 10657288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 9381027 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognex (donepezil) treatment, specific dosage and duration not mentioned
Number of subjects: 0
Study 8317820 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled PGE2 (100 micrograms)
Number of subjects: 8
Study 3519736 — intervention group
Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) group
Number of subjects: 0
Study 3519736 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) group
Number of subjects: 0
Study 29536252 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% administered for local wound infiltration
Number of subjects: 60
Study 29536252 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 60
Study 27494527 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fasting blood glucose (FBG)
Number of subjects: 2862
Study 27494527 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 2862
Study 27494527 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher NIHSS
Number of subjects: 2862
Study 27494527 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 2862
Study 27494527 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fasting blood glucose (FBG) in patients without pre-diagnosed diabetes
Number of subjects: 2862
Study 27494527 — intervention group
Group type: COMPARATOR
Intervention: Elevated fasting blood glucose (FBG) in patients with pre-diagnosed diabetes
Number of subjects: 2862
Study 23898989 — intervention group
Group type: EXPERIMENTAL
Intervention: RQ (n = 17)
Number of subjects: 32
Study 23898989 — intervention group
Group type: EXPERIMENTAL
Intervention: VT (n = 15)
Number of subjects: 32
Study 23898989 — intervention group
Group type: COMPARATOR
Intervention: RQ and VT
Number of subjects: 32
Study 22791991 — intervention group
Group type: EXPERIMENTAL
Intervention: Roflumilast 500 μg once daily
Number of subjects: 967
Study 22791991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 967
Study 21120297 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Anesthetic with Vasoconstrictor (LAVA; 2% mepivacaine with adrenaline 1:100,000)
Number of subjects: 37
Study 21120297 — intervention group
Group type: COMPARATOR
Intervention: No Local Anesthetic
Number of subjects: 37
Study 18559704 — intervention group
Group type: EXPERIMENTAL
Intervention: SFJ ligation with polytetrafluoroethylene patch
Number of subjects: 292
Study 18559704 — intervention group
Group type: COMPARATOR
Intervention: SFJ ligation surgery
Number of subjects: 292
Study 15532135 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 624
Study 11744467 — intervention group
Group type: EXPERIMENTAL
Intervention: Saw palmetto
Number of subjects: 85
Study 11744467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 9503259 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine treatment (24 +/- 15 months prior to study)
Number of subjects: 40
Study 9503259 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine treatment (6 weeks)
Number of subjects: 40
Study 8281590 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 23
Study 8281590 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 23
Study 3732427 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg of fenoterol in powder form
Number of subjects: 20
Study 3732427 — intervention group
Group type: COMPARATOR
Intervention: 0.2 mg of fenoterol in MDI form
Number of subjects: 20
Study 3732427 — intervention group
Group type: COMPARATOR
Intervention: Placebo powder
Number of subjects: 20
Study 31805869 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalizing the address, enclosing a $2 cash incentive with the initial questionnaire mailing, and repeated follow-up mailings
Number of subjects: 4080
Study 31805869 — intervention group
Group type: COMPARATOR
Intervention: Survey incentive, survey length, number of follow-up waves, field study incentive, age, or sex
Number of subjects: 4080
Study 28188479 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium dose UVB irradiation (0.70 minimal erythema dose)
Number of subjects: 6
Study 28188479 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose UVB irradiation (1.75 minimal erythema dose)
Number of subjects: 6
Study 28188479 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose UVB irradiation (0.28 minimal erythema dose)
Number of subjects: 6
Study 28188479 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal weight subjects receiving medium dose UVB irradiation
Number of subjects: 6
Study 28188479 — intervention group
Group type: COMPARATOR
Intervention: Obese control group (no treatment)
Number of subjects: 6
Study 28188479 — intervention group
Group type: COMPARATOR
Intervention: Normal weight control group (no treatment)
Number of subjects: 6
Study 28188479 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of obese patients to normal weight controls irradiated with equal UVB doses
Number of subjects: 6
Study 28188479 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25D levels
Number of subjects: 6
Study 26741127 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin 4 mg daily
Number of subjects: 15
Study 25136048 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS) 100000 IU for 6-11 months, 200000 IU for 12-23 months
Number of subjects: 7587
Study 25136048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7587
Study 22585090 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (1100 IU/d)
Number of subjects: 1179
Study 22585090 — intervention group
Group type: EXPERIMENTAL
Intervention: Increase in vitamin D intake
Number of subjects: 1179
Study 22585090 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum 25(OH)D level
Number of subjects: 1179
Study 22585090 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline blood collection season
Number of subjects: 1179
Study 22585090 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline serum calcium level
Number of subjects: 1179
Study 22585090 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline body mass index
Number of subjects: 1179
Study 19594042 — intervention group
Group type: EXPERIMENTAL
Intervention: Knife needle treatment for 3 weeks
Number of subjects: 69
Study 19594042 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture treatment for 3 weeks
Number of subjects: 69
Study 17469105 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab treatment
Number of subjects: 15
Study 15333303 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental intervention to increase availability of lower-fat foods and student-based promotions
Number of subjects: 20
Study 15333303 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 20
Study 11424822 — intervention group
Group type: EXPERIMENTAL
Intervention: ECG-guided technique (group A)
Number of subjects: 44
Study 11424822 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (group B)
Number of subjects: 44
Study 9060535 — intervention group
Group type: EXPERIMENTAL
Intervention: Replens (polycarbophil-based vaginal moisturizer)
Number of subjects: 45
Study 9060535 — intervention group
Group type: COMPARATOR
Intervention: Placebo lubricating product
Number of subjects: 45
Study 8351679 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimethicone (Gel de Polysilane Midy) with ethyl biscoumacetate (300 mg)
Number of subjects: 6